- Market Capitalization, $K 306,388
- Shares Outstanding, K 74,547
- Annual Sales, $ 138,140 K
- Annual Income, $ -53,020 K
- 60-Month Beta 1.65
- Price/Sales 2.16
- Price/Cash Flow N/A
- Price/Book 2.14
|Period||Period Low||Period High||Performance|
| || |
-2.77 (-40.26%)since 02/05/21
| || |
-2.03 (-33.12%)since 12/04/20
| || |
+0.98 (+31.31%)since 03/05/20
Stocks Can't Follow Through on Recent Rally
Collaboration Agreement to Market AZOVA COVID-19 Test Collection Kit Online
S&P Snaps Five-Day Losing Streak as Stocks Rally Late
, /PRNewswire/ -- The report has been added to offering.
Fluidigm (FLDM) delivered earnings and revenue surprises of -225.00% and -11.26%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
SOUTH SAN FRANCISCO, Calif. (AP) _ Fluidigm Corp. (FLDM) on Wednesday reported a loss of $18 million in its fourth quarter.
Fourth Quarter Total Revenue Increased 38 Percent to $44.6 million
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that George Mason University in Fairfax,...
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a supply and distribution agreement with...
NEW YORK, NY / ACCESSWIRE / February 10, 2021 / Fluidigm Corp. (NASDAQ:FLDM) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 10, 2021 at 5:00...
|Resources Prospect Ltd|
|Micro-Cap Ishares ETF|
|Principal Healthcare Innovators Index|
|Oppenheimer Russell 2000 Multifactor ETF|
|GS Activebeta U.S. Small Cap Equity ETF|